Reference | Year of publication | Quality score | Concealment | Study size | Mean age of subjects | Outpatients or inpatients | Treatment | Duration(days) | Early follow-up(days) | Late follow-up(days) |
Langan45 | 1998 | 4 | Unknown | 684 | 55.9 | Outpatients | Cefuroxime | 5 | 8–10 | 28–35 |
57.1 | Claritromycin | 7 | ||||||||
Lorenz46 | 1998 | 4 | Unknown | 222 | 56.0 | Unknown | Cefixime | 5 | 10–13 | 27–33 |
54.0 | Cefixime | 10 | ||||||||
Langan21 | 1999 | 4 | Unknown | 544 | 56.8 | Outpatients | Grepafloxacin | 5 | 11–13 | 31–38 |
56.3 | Grepafloxacin | 10 | ||||||||
Wasilewski (a)22 | 1999 | 5 | Adequate | 499 | 52.0 | Outpatients | Dirithromycin | 5 | 10–12 | 17–21 |
52.0 | Erythromycin | 7 | ||||||||
Wasilewski (b)22 | 1999 | 5 | Adequate | 558 | 52.0 | Outpatients | Dirithromycin | 5 | 10–12 | 17–21 |
52.0 | Erythromycin | 7 | ||||||||
Wilson47 | 1999 | 4 | Unknown | 750 | 60.0 | Both | Moxifloxacin | 5 | 14 | 28–35 |
60.2 | Claritromycin | 7 | ||||||||
Chodosh19 | 2000 | 5 | Adequate | 614 | 56.9 | Outpatients | Moxifloxacin | 5 | 10–16 | 17–27 |
56.2 | Moxifloxacin | 10 | ||||||||
File48 | 2000 | 4 | Unknown | 600 | 64.2 | Outpatients | Gemifloxacin | 5 | 14–21 | 28–35 |
64.0 | Co-amoxiclav | 7 | ||||||||
Fogarty23 | 2000 | 4 | Unknown | 548 | 54.0 | Unknown | Cefdinir | 5 | 17–21 | 28–42 |
57.0 | Cefprozil | 10 | ||||||||
Paster26 | 2000 | 5 | Adequate | 586 | 54.0 | Outpatients | Cefdinir | 5 | 12–19 | 26–40 |
52.0 | Loracerbef | 7 | ||||||||
Gotfried20 | 2001 | 2 | Unknown | 349 | 48.0 | Outpatients | Gatifloxacin | 5 | 14–21 | 28–35 |
49.0 | Gatifloxacin | 7 | ||||||||
Masterton49 | 2001 | 3 | Unknown | 532 | 60.7 | Outpatients | Levofloxacin | 5 | 14–17 | 35–42 |
59.5 | Levofloxacin | 7 | ||||||||
Aubier50 | 2002 | 4 | Unknown | 325 | 61.5 | Outpatients | Telithromycin | 5 | 17–21 | 31–36 |
66.0 | Co-clavulanate | 10 | ||||||||
Wilson25 | 2002 | 3 | Unknown | 712 | 58.7 | Inpatients | Gemifloxacin | 5 | 14–21 | 28–35 |
58.4 | Claritromycin | 7 | ||||||||
Soler51 | 2003 | 3 | Unknown | 282 | 60.1 | Both | Gatifloxacin | 5 | 11–14 | 31–38 |
61.9 | Co-clavulanate | 10 | ||||||||
Zervos52 | 2003 | 5 | Adequate | 376 | 50.5 | Unknown | Telithromycin | 5 | 17–24 | 31–45 |
57.0 | Cefuroxime | 10 | ||||||||
Sethi53 | 2004 | 5 | Adequate | 360 | 61.6 | Unknown | Gemifloxacin | 5 | 14–21 | 28–35 |
63.4 | Levofloxacin | 7 | ||||||||
Fogarty54 | 2005 | 3 | Unknown | 650 | 59.5 | Outpatients | Telithromycin | 5 | 17–24 | 31–36 |
59.4 | Clarithromycin | 10 | ||||||||
Gotfried24 | 2005 | 4 | Unknown | 485 | 62.1 | Outpatients | Clarithromycin | 5 | 17–21 | 37–40 |
61.6 | Clarithromycin | 7 | ||||||||
Sethi55 | 2005 | 4 | Unknown | 893 | 60.1 | Both | Co-amoxiclav 2000/125 | 5 | 14–21 | 28–35 |
60.3 | Co-amoxiclav 875/125 | 7 | ||||||||
Alvarez-Sala27 | 2006 | 3 | Unknown | 541 | 61.1 | Unknown | Cefditoren pivoxil | 5 | 10–12 | 25–35 |
61.0 | Cefuroxime | 10 |